ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in San Diego, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Coronavirus Infections
Human Influenza
Communicable Diseases
Post-Acute COVID-19 Syndrome
Syndrome
Pneumonia

COVID-19 trials near San Diego, CA, USA:

Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19

This is a pilot phase, open label, non-randomized study for the treatment of ARDS in patients infected with COVID-19. Subjects will...

Active, not recruiting
Covid-19
ARDS, Human
Biological: Mesenchymal Stem Cells derived from Wharton Jelly of Umbilical cords

Early Phase 1

Instituto de Medicina Regenerativa

Tijuana, Baja California, Mexico

A study to investigate the prevention of COVID-19 with VYD222 in adults with immune compromise and in participants aged 12 years or...

Active, not recruiting
COVID-19
SARS-CoV-2
Drug: VYD222 (pemivibart)
Drug: Normal saline

Phase 3

Invivyd

San Diego, California, United States and 17 other locations

a completed primary series and bivalent booster of mRNA based COVID-19 vaccine and have =\<2500 U/mL SARS-CoV-2 S antibody concentr...

Active, not recruiting
COVID-19
Kidney Transplant
Biological: Sanofi-GSK monovalent (B.1.351) CoV2 preS dTM-AS03 COVID-19 vaccine

Phase 2

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

San Diego, California, United States and 5 other locations

The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-...

Active, not recruiting
COVID-19
Biological: mRNA-1283.222
Biological: mRNA-1273.815

Phase 3

Moderna
Moderna

San Diego, California, United States and 217 other locations

This is an exploratory Phase I, randomized, observer-blind, active-controlled, dose-escalation trial to evaluate four dose levels (DLs) of BNT162b4 g...

Active, not recruiting
COVID-19
SARS-CoV-2 Infection
Biological: BNT162b4 10 µg
Biological: BNT162b4 15 µg

Phase 1

BioNTech
BioNTech

San Diego, California, United States and 16 other locations

(SARS-CoV2) vaccine tablet VXA-CoV2-3.1 compared to a currently recommended vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID...

Enrolling
COVID-19
SARS-CoV2
Biological: VXA-CoV2-3.1
Biological: COMIRNATY®

Phase 2

Vaxart

Chula Vista, California, United States and 144 other locations

known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...

Active, not recruiting
COVID-19, SARS-CoV-2
Biological: AZD3152 (Sub-study)
Biological: Placebo (Parent study Sentinel Safety Cohort)

Phase 2, Phase 3

AstraZeneca
AstraZeneca

La Mesa, California, United States and 214 other locations

This study is to learn about flu and COVID vaccines, either alone or when mixed together. Healthy people aged 18 or older can join. Participants will...

Not yet enrolling
COVID-19
Influenza,Human
Biological: COVID-19 Vaccine
Biological: Investigational Influenza Vaccine

Phase 1, Phase 2

BioNTech
BioNTech

San Diego, California, United States of America and 4 other locations

Locations recently updated

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling
COVID-19
Parainfluenza
Drug: DAS181 COVID-19
Drug: DAS181

Phase 3

Ansun Biopharma

San Diego, California, United States and 66 other locations

The purpose of this study is to evaluate the safety, reactogenicity and immune responses of the severe acute respiratory syndrome coronavirus 2 (SARS...

Active, not recruiting
COVID-19
Drug: Placebo
Biological: mRNA-CR-04 vaccine 3μg

Phase 1

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

San Diego, California, United States and 3 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems